Skip to main content
Erschienen in: Acta Diabetologica 4/2013

01.08.2013 | Original Article

Relationship between urinary bisphenol A levels and prediabetes among subjects free of diabetes

verfasst von: Charumathi Sabanayagam, Srinivas Teppala, Anoop Shankar

Erschienen in: Acta Diabetologica | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Bisphenol A (BPA) is a high volume production chemical used in the manufacture of polycarbonate plastics and epoxy resins. Recent experimental studies have suggested that BPA affects glucose metabolism through diverse mechanisms including insulin resistance, pancreatic β-cell dysfunction, adipogenesis, inflammation and oxidative stress. Prediabetes is a stage earlier in the hyperglycemia continuum associated with increased future risk of developing diabetes. Therefore, we examined the association between BPA exposure and prediabetes among subjects free of diabetes. We examined the association between urinary BPA levels and prediabetes in 3,516 subjects from the National Health and Nutritional Examination Survey 2003–2008. Urinary BPA levels were examined in tertiles. Prediabetes was defined as fasting glucose concentration 100–125 mg/dL or 2-h glucose concentration of 140–199 mg/dL or an A1C value of 5.7–6.4 %. Overall, we observed a positive association between higher levels of urinary BPA and prediabetes, independent of potential confounders including body mass index, alcohol intake, blood pressure and serum cholesterol levels. Compared to tertile 1 (referent), the multivariate-adjusted odds ratio (95 % confidence interval) of prediabetes associated with tertile 3 of BPA was 1.34 (1.03–1.73), p-trend = 0.02. In subgroup analysis, this association was stronger among women and obese subjects. Higher urinary BPA levels are found to be associated with prediabetes independent of traditional diabetes risk factors. Future prospective studies are needed to confirm or disprove this finding.
Literatur
1.
Zurück zum Zitat Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391–395PubMedCrossRef Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391–395PubMedCrossRef
2.
Zurück zum Zitat Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139–177PubMedCrossRef Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139–177PubMedCrossRef
3.
Zurück zum Zitat Adachi T, Yasuda K, Mori C et al (2005) Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem Toxicol 43:713–719PubMedCrossRef Adachi T, Yasuda K, Mori C et al (2005) Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem Toxicol 43:713–719PubMedCrossRef
4.
Zurück zum Zitat Sakurai K, Kawazuma M, Adachi T et al (2004) Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141:209–214PubMedCrossRef Sakurai K, Kawazuma M, Adachi T et al (2004) Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141:209–214PubMedCrossRef
5.
Zurück zum Zitat Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106–112PubMedCrossRef Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106–112PubMedCrossRef
6.
Zurück zum Zitat Gerich JE (2003) Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447–456PubMedCrossRef Gerich JE (2003) Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447–456PubMedCrossRef
7.
Zurück zum Zitat Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A (2008) Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31:194–200PubMedCrossRef Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A (2008) Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31:194–200PubMedCrossRef
8.
Zurück zum Zitat Kawasaki T, Igarashi K, Ogata N, Oka Y, Ichiyanagi K, Yamanouchi T (2010) Markedly increased serum and urinary fructose concentrations in diabetic patients with ketoacidosis or ketosis. Acta Diabetol 49:119–123 Kawasaki T, Igarashi K, Ogata N, Oka Y, Ichiyanagi K, Yamanouchi T (2010) Markedly increased serum and urinary fructose concentrations in diabetic patients with ketoacidosis or ketosis. Acta Diabetol 49:119–123
9.
Zurück zum Zitat Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310PubMedCrossRef Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310PubMedCrossRef
10.
Zurück zum Zitat Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS (2010) Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 5:e8673PubMedCrossRef Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS (2010) Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 5:e8673PubMedCrossRef
11.
Zurück zum Zitat American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes 413 Care 33 (suppl 1):S11–S61 American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes 413 Care 33 (suppl 1):S11–S61
12.
Zurück zum Zitat Leiter LA (2006) From hyperglycemia to the risk of cardiovascular disease. Rev Cardiovasc Med 7(Suppl 2):S3–S9PubMed Leiter LA (2006) From hyperglycemia to the risk of cardiovascular disease. Rev Cardiovasc Med 7(Suppl 2):S3–S9PubMed
13.
Zurück zum Zitat Gabir MM, Hanson RL, Dabelea D et al (2000) Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23:1113–1118PubMedCrossRef Gabir MM, Hanson RL, Dabelea D et al (2000) Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23:1113–1118PubMedCrossRef
14.
Zurück zum Zitat Schaefer C, Biermann T, Schroeder M et al (2010) Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia. Acta Diabetol 47:19–27PubMedCrossRef Schaefer C, Biermann T, Schroeder M et al (2010) Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia. Acta Diabetol 47:19–27PubMedCrossRef
15.
Zurück zum Zitat Zheng X, Ren W, Zhang S et al (2010) Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus. Acta Diabetol 47:265–270PubMedCrossRef Zheng X, Ren W, Zhang S et al (2010) Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus. Acta Diabetol 47:265–270PubMedCrossRef
16.
Zurück zum Zitat Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedCrossRef Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedCrossRef
17.
Zurück zum Zitat National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: survey operations manuals (Article online) National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: survey operations manuals (Article online)
18.
Zurück zum Zitat National Center for Health Statistics (2010) 2005–2006 National Health and Nutrition Examination Survey: survey operations manuals (Article online) National Center for Health Statistics (2010) 2005–2006 National Health and Nutrition Examination Survey: survey operations manuals (Article online)
19.
Zurück zum Zitat National Center for Health Statistics (2010) 2007–2008 National Health and Nutrition Examination Survey: survey operations manuals (Article online) National Center for Health Statistics (2010) 2007–2008 National Health and Nutrition Examination Survey: survey operations manuals (Article online)
25.
Zurück zum Zitat Ye X, Kuklenyik Z, Needham LL, Calafat AM (2005) Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 77:5407–5413PubMedCrossRef Ye X, Kuklenyik Z, Needham LL, Calafat AM (2005) Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 77:5407–5413PubMedCrossRef
26.
Zurück zum Zitat National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: laboratory procedures (Article online) National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: laboratory procedures (Article online)
27.
Zurück zum Zitat Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34(suppl 1):S62–S69 Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34(suppl 1):S62–S69
28.
Zurück zum Zitat Kehoe R, Wu SY, Leske MC, Chylack LT Jr (1994) Comparing self-reported and physician-reported medical history. Am J Epidemiol 139:813–818PubMed Kehoe R, Wu SY, Leske MC, Chylack LT Jr (1994) Comparing self-reported and physician-reported medical history. Am J Epidemiol 139:813–818PubMed
29.
Zurück zum Zitat Szklo M, Nieto FJ (2007) Epidemiology: beyond the basics Szklo M, Nieto FJ (2007) Epidemiology: beyond the basics
30.
Zurück zum Zitat Rubin BS, Soto AM, Bisphenol A (2009) Perinatal exposure and body weight. Mol Cell Endocrinol 304:55–62PubMedCrossRef Rubin BS, Soto AM, Bisphenol A (2009) Perinatal exposure and body weight. Mol Cell Endocrinol 304:55–62PubMedCrossRef
31.
Zurück zum Zitat Guo L, Cheng Y, Wang X et al (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol 49:S65–S71 Guo L, Cheng Y, Wang X et al (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol 49:S65–S71
32.
Zurück zum Zitat Ben-Jonathan N, Hugo ER, Brandebourg TD (2009) Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol 304:49–54PubMedCrossRef Ben-Jonathan N, Hugo ER, Brandebourg TD (2009) Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol 304:49–54PubMedCrossRef
33.
Zurück zum Zitat Bindhumol V, Chitra KC, Mathur PP (2003) Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 188:117–124PubMedCrossRef Bindhumol V, Chitra KC, Mathur PP (2003) Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 188:117–124PubMedCrossRef
34.
Zurück zum Zitat Kim MJ, Jung HS, Hwang-Bo Y et al (2011) Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print] Kim MJ, Jung HS, Hwang-Bo Y et al (2011) Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print]
35.
Zurück zum Zitat Wada K, Sakamoto H, Nishikawa K et al (2007) Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci 105:133–137PubMedCrossRef Wada K, Sakamoto H, Nishikawa K et al (2007) Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci 105:133–137PubMedCrossRef
36.
Zurück zum Zitat Sargis RM, Johnson DN, Choudhury RA, Brady MJ (2010) Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 18:1283–1288CrossRef Sargis RM, Johnson DN, Choudhury RA, Brady MJ (2010) Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 18:1283–1288CrossRef
37.
Zurück zum Zitat Moriyama K, Tagami T, Akamizu T et al (2002) Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185–5190PubMedCrossRef Moriyama K, Tagami T, Akamizu T et al (2002) Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185–5190PubMedCrossRef
38.
Zurück zum Zitat Teeguarden JG, Calafat AM, Ye X et al (2011) Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci 123:48–57PubMedCrossRef Teeguarden JG, Calafat AM, Ye X et al (2011) Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci 123:48–57PubMedCrossRef
39.
Zurück zum Zitat Hengstler JG, Foth H, Gebel T et al (2011) Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 41:263–291PubMedCrossRef Hengstler JG, Foth H, Gebel T et al (2011) Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 41:263–291PubMedCrossRef
40.
Zurück zum Zitat Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H (2004) Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem 14:57–63CrossRef Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H (2004) Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem 14:57–63CrossRef
41.
Zurück zum Zitat Fernandez MF, Arrebola JP, Taoufiki J et al (2007) Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 24:259–264PubMedCrossRef Fernandez MF, Arrebola JP, Taoufiki J et al (2007) Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 24:259–264PubMedCrossRef
42.
Zurück zum Zitat Nunez AA, Kannan K, Giesy JP, Fang J, Clemens LG (2001) Effects of bisphenol A on energy balance and accumulation in brown adipose tissue in rats. Chemosphere 42:917–922PubMedCrossRef Nunez AA, Kannan K, Giesy JP, Fang J, Clemens LG (2001) Effects of bisphenol A on energy balance and accumulation in brown adipose tissue in rats. Chemosphere 42:917–922PubMedCrossRef
43.
Zurück zum Zitat Carwile JL, Michels KB (2011) Urinary bisphenol A and obesity: NHANES 2003–2006. Environ Res 111:825–830PubMedCrossRef Carwile JL, Michels KB (2011) Urinary bisphenol A and obesity: NHANES 2003–2006. Environ Res 111:825–830PubMedCrossRef
44.
Zurück zum Zitat Thorand B, Baumert J, Kolb H et al (2007) Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care 30:854–860PubMedCrossRef Thorand B, Baumert J, Kolb H et al (2007) Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care 30:854–860PubMedCrossRef
45.
Zurück zum Zitat Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288–1299PubMedCrossRef Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288–1299PubMedCrossRef
46.
Zurück zum Zitat Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ Health Perspect 116:39–44PubMedCrossRef Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ Health Perspect 116:39–44PubMedCrossRef
47.
Zurück zum Zitat Mahalingaiah S, Meeker JD, Pearson KR et al (2008) Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect 116:173–178PubMedCrossRef Mahalingaiah S, Meeker JD, Pearson KR et al (2008) Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect 116:173–178PubMedCrossRef
48.
Zurück zum Zitat Braun JM, Kalkbrenner AE, Calafat AM et al (2011) Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 119:131–137PubMedCrossRef Braun JM, Kalkbrenner AE, Calafat AM et al (2011) Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 119:131–137PubMedCrossRef
49.
Zurück zum Zitat Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM Jr (2000) The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54:3–18PubMedCrossRef Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM Jr (2000) The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54:3–18PubMedCrossRef
50.
Zurück zum Zitat Ye X, Wong LY, Bishop AM, Calafat AM (2011) Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 119:983–988PubMedCrossRef Ye X, Wong LY, Bishop AM, Calafat AM (2011) Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 119:983–988PubMedCrossRef
52.
Zurück zum Zitat Schulze MB, Manson JE, Ludwig DS et al (2004) Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292:927–934PubMedCrossRef Schulze MB, Manson JE, Ludwig DS et al (2004) Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292:927–934PubMedCrossRef
Metadaten
Titel
Relationship between urinary bisphenol A levels and prediabetes among subjects free of diabetes
verfasst von
Charumathi Sabanayagam
Srinivas Teppala
Anoop Shankar
Publikationsdatum
01.08.2013
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 4/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0472-z

Weitere Artikel der Ausgabe 4/2013

Acta Diabetologica 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.